查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317730

免疫球蛋白产品市场：按类型（IGA、IGD、IGE）、ROA（IMIG、IVIG、SCIG）、按用途- 2023-2030 年全球预测

Immunoglobulin Product Market by Type (IGA, IGD, IGE), ROA (IMIG, IVIG, SCIG), Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球免疫球蛋白产品市场将达138.6亿美元，年复合成长率为11.19%，预计2030年将达292.4亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球免疫球蛋白产品市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 免疫球蛋白产品的全球市场规模及预测为何？

2.在预测期内，COVID-19 对全球免疫球蛋白产品市场的阻碍因素和影响为何？

3. 在预测期内，全球免疫球蛋白产品市场需要投资哪些产品/细分市场/应用/领域？

4. 你们在全球免疫球蛋白产品市场的竞争策略是什么？

5. 全球免疫球蛋白产品市场的技术趋势和法律规范是什么？

6. 全球免疫球蛋白产品市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球免疫球蛋白产品市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 免疫缺陷疾病增加
      • 世界各地的老年人口正在增加
      • 免疫球蛋白产品的采用迅速增加
    • 抑制因素
      • 免疫球蛋白产品高成本且副作用大
    • 机会
      • 免疫球蛋白的持续研究和开发活动
      • 新型和先进的免疫球蛋白产品介绍
    • 任务
      • 治理机构对产品核可严格的规则和规范
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章免疫球蛋白产品市场：依类型

  • 伊贺
  • IGD
  • IGE
  • IGG
  • IGM

第7章按 ROA 分類的免疫球蛋白产品市场

  • IMIG
  • IVIG
  • SCIG

第8章免疫球蛋白产品市场：依用途

  • CIDP
  • CLL
  • 先天性爱滋病
  • 低丙种球蛋白血症
  • ITP
  • 免疫缺陷症
  • 川崎病
  • 多灶性运动神经病变
  • 重症肌无力

第9章美洲免疫球蛋白产品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太免疫球蛋白产品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲免疫球蛋白产品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-43127F7279C6

The Global Immunoglobulin Product Market is forecasted to grow significantly, with a projected USD 13.86 billion in 2023 at a CAGR of 11.19% and expected to reach a staggering USD 29.24 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoglobulin Product Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoglobulin Product Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across IGA, IGD, IGE, IGG, and IGM. The IGD is projected to witness significant market share during forecast period.

Based on ROA, market is studied across IMIG, IVIG, and SCIG. The IVIG is projected to witness significant market share during forecast period.

Based on Application, market is studied across CIDP, CLL, Congenital AIDS, Hypogammaglobulinemia, ITP, Immunodeficiency Diseases, Kawasaki Disease, Multifocal Motor Neuropathy, and Myasthenia Gravis. The Multifocal Motor Neuropathy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35.36% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoglobulin Product Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoglobulin Product Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoglobulin Product Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoglobulin Product Market?

4. What is the competitive strategic window for opportunities in the Global Immunoglobulin Product Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoglobulin Product Market?

6. What is the market share of the leading vendors in the Global Immunoglobulin Product Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoglobulin Product Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Immunoglobulin Product Market, by Type, 2022 vs 2030
  • 4.3. Immunoglobulin Product Market, by ROA, 2022 vs 2030
  • 4.4. Immunoglobulin Product Market, by Application, 2022 vs 2030
  • 4.5. Immunoglobulin Product Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the Cases of Immunodeficiency Diseases
      • 5.1.1.2. Growing Geriatric Population Around the World
      • 5.1.1.3. Surge in the Adoption of Immunoglobulin Products
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost and Adverse Effects of the Immunoglobulin Products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Research and Development Activities in the Immunoglobulin
      • 5.1.3.2. Introduction of New & Advanced Immunoglobulin Products
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Rules and Norms of Governing Bodies for Product Approval
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Immunoglobulin Product Market, by Type

  • 6.1. Introduction
  • 6.2. IGA
  • 6.3. IGD
  • 6.4. IGE
  • 6.5. IGG
  • 6.6. IGM

7. Immunoglobulin Product Market, by ROA

  • 7.1. Introduction
  • 7.2. IMIG
  • 7.3. IVIG
  • 7.4. SCIG

8. Immunoglobulin Product Market, by Application

  • 8.1. Introduction
  • 8.2. CIDP
  • 8.3. CLL
  • 8.4. Congenital AIDS
  • 8.5. Hypogammaglobulinemia
  • 8.6. ITP
  • 8.7. Immunodeficiency Diseases
  • 8.8. Kawasaki Disease
  • 8.9. Multifocal Motor Neuropathy
  • 8.10. Myasthenia Gravis

9. Americas Immunoglobulin Product Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoglobulin Product Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoglobulin Product Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IMMUNOGLOBULIN PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2022 VS 2030 (%)
  • FIGURE 6. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. IMMUNOGLOBULIN PRODUCT MARKET DYNAMICS
  • FIGURE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IMMUNOGLOBULIN PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 152. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 153. IMMUNOGLOBULIN PRODUCT MARKET LICENSE & PRICING